Skip to main content
Erschienen in: International Urology and Nephrology 5/2021

12.01.2021 | Nephrology - Original Paper

Osteocalcin and vascular calcification in hemodialysis patients: an observational cohort study

verfasst von: Hesham Kamal Habeeb Keryakos, Nagwa Ismail Okaily, Mariam Asaad Yacoub Boulis, Ahmed Mohamed Saadeldin Salama

Erschienen in: International Urology and Nephrology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Vascular calcification contributes to morbidity and mortality in patients with ESRD on maintenance hemodialysis.

Aims

To study the relationship between osteocalcin and vascular calcification.

Methods

160 patients with ESRD on maintenance hemodialysis and 60 age-and sex-matched healthy controls were recruited. Serum vitamin K2 and osteocalcin both intact and undercarboxylated were measured. Transthoracic echocardiography was done for valvular calcification and thickening, and carotid duplex was done for carotid intimal medial calcification and thickening.

Results

Hemodialysis patients have higher median serum vitamin K2 (p < 0.001), higher undercarboxylated osteocalcin (p < 0.001). Only older age, duration of hypertension, and duration of established cardiovascular disease are associated with carotid media-intimal calcification. Old age is a strong predictor of carotid media intimal thickening. Female sex is associated with a valvular thickening.

Conclusions

Functional vitamin K deficiency is present in maintenance hemodialysis patients and serum osteocalcin is not associated with cardiovascular calcification.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ruderman I, Holt SG, Hewitson TD, Smith ER, Toussaint ND (2018) Current and potential therapeutic strategies for the management of vascular calcification in patients with chronic kidney disease including those on dialysis. Semin Dial 31(5):487–499CrossRef Ruderman I, Holt SG, Hewitson TD, Smith ER, Toussaint ND (2018) Current and potential therapeutic strategies for the management of vascular calcification in patients with chronic kidney disease including those on dialysis. Semin Dial 31(5):487–499CrossRef
2.
Zurück zum Zitat Mizuiri S, Nishizawa Y, Yamashita K, Ono K, Naito T, Tanji C et al (2019) Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients. Ren Fail 41(1):770–777CrossRef Mizuiri S, Nishizawa Y, Yamashita K, Ono K, Naito T, Tanji C et al (2019) Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients. Ren Fail 41(1):770–777CrossRef
3.
Zurück zum Zitat Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli S et al (2009) Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients. Artif Organs 33(10):844–854CrossRef Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli S et al (2009) Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients. Artif Organs 33(10):844–854CrossRef
4.
Zurück zum Zitat Fusaro M, Gallieni M, Rizzo MA, Stucchi A, Delanaye P, Cavalier E et al (2017) Vitamin K plasma levels determination in human health. Clin Chem Lab Med 55(6):789–799CrossRef Fusaro M, Gallieni M, Rizzo MA, Stucchi A, Delanaye P, Cavalier E et al (2017) Vitamin K plasma levels determination in human health. Clin Chem Lab Med 55(6):789–799CrossRef
5.
Zurück zum Zitat Millar SA, Patel H, Anderson SI, England TJ, O’Sullivan SE (2017) Osteocalcin, vascular calcification, and atherosclerosis: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 8:183CrossRef Millar SA, Patel H, Anderson SI, England TJ, O’Sullivan SE (2017) Osteocalcin, vascular calcification, and atherosclerosis: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 8:183CrossRef
6.
Zurück zum Zitat Seidu S, Kunutsor SK, Khunti K (2019) Association of circulating osteocalcin with cardiovascular disease and intermediate cardiovascular phenotypes: systematic review and meta-analysis. Scand Cardiovasc J 53(6):286–295CrossRef Seidu S, Kunutsor SK, Khunti K (2019) Association of circulating osteocalcin with cardiovascular disease and intermediate cardiovascular phenotypes: systematic review and meta-analysis. Scand Cardiovasc J 53(6):286–295CrossRef
7.
Zurück zum Zitat Kim KM, Lim S, Moon JH, Jin H, Jung KY, Shin CS et al (2016) Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease. Bone 83:178–183CrossRef Kim KM, Lim S, Moon JH, Jin H, Jung KY, Shin CS et al (2016) Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease. Bone 83:178–183CrossRef
8.
Zurück zum Zitat D’Onofrio L, Maddaloni E, Buzzetti R (2019) Osteocalcin and sclerostin: background characters or main actors in cardiovascular disease? Diabetes Metab Res Rev 2:e3217 D’Onofrio L, Maddaloni E, Buzzetti R (2019) Osteocalcin and sclerostin: background characters or main actors in cardiovascular disease? Diabetes Metab Res Rev 2:e3217
9.
Zurück zum Zitat Holden RM, Iliescu E, Morton AR, Booth SL (2008) Vitamin K status of Canadian peritoneal dialysis patients. Perit Dial Int 28(4):415–418CrossRef Holden RM, Iliescu E, Morton AR, Booth SL (2008) Vitamin K status of Canadian peritoneal dialysis patients. Perit Dial Int 28(4):415–418CrossRef
10.
Zurück zum Zitat Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL (2010) Vitamins K and D status in stages 3–5 chronic kidney disease. Clin J Am Soc Nephrol 5(4):590–597CrossRef Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL (2010) Vitamins K and D status in stages 3–5 chronic kidney disease. Clin J Am Soc Nephrol 5(4):590–597CrossRef
11.
Zurück zum Zitat Price PA, Faus SA, Williamson MK (1998) Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18(9):1400–1407CrossRef Price PA, Faus SA, Williamson MK (1998) Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18(9):1400–1407CrossRef
12.
Zurück zum Zitat Weijs B, Blaauw Y, Rennenberg RJ, Schurgers LJ, Timmermans CC, Pison L et al (2011) Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J 32(20):2555–2562CrossRef Weijs B, Blaauw Y, Rennenberg RJ, Schurgers LJ, Timmermans CC, Pison L et al (2011) Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J 32(20):2555–2562CrossRef
13.
Zurück zum Zitat Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C (2007) Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109(7):2823–2831CrossRef Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C (2007) Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109(7):2823–2831CrossRef
14.
Zurück zum Zitat McCabe KM, Booth SL, Fu X, Ward E, Adams MA, Holden RM (2017) Vitamin K metabolism in a rat model of chronic kidney disease. Am J Nephrol 45(1):4–13CrossRef McCabe KM, Booth SL, Fu X, Ward E, Adams MA, Holden RM (2017) Vitamin K metabolism in a rat model of chronic kidney disease. Am J Nephrol 45(1):4–13CrossRef
15.
Zurück zum Zitat Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S et al (2012) Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 59(2):186–195CrossRef Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S et al (2012) Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 59(2):186–195CrossRef
16.
Zurück zum Zitat Oikonomaki T, Papasotiriou M, Ntrinias T, Kalogeropoulou C, Zabakis P, Kalavrizioti D et al (2019) The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial. Int Urol Nephrol 51(11):2037–2044CrossRef Oikonomaki T, Papasotiriou M, Ntrinias T, Kalogeropoulou C, Zabakis P, Kalavrizioti D et al (2019) The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial. Int Urol Nephrol 51(11):2037–2044CrossRef
17.
Zurück zum Zitat Schlieper G, Westenfeld R, Kruger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM et al (2011) Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 22(2):387–395CrossRef Schlieper G, Westenfeld R, Kruger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM et al (2011) Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 22(2):387–395CrossRef
18.
Zurück zum Zitat Cranenburg EC, Schurgers LJ, Uiterwijk HH, Beulens JW, Dalmeijer GW, Westerhuis R et al (2012) Vitamin K intake and status are low in hemodialysis patients. Kidney Int 82(5):605–610CrossRef Cranenburg EC, Schurgers LJ, Uiterwijk HH, Beulens JW, Dalmeijer GW, Westerhuis R et al (2012) Vitamin K intake and status are low in hemodialysis patients. Kidney Int 82(5):605–610CrossRef
19.
Zurück zum Zitat Pilkey RM, Morton AR, Boffa MB, Noordhof C, Day AG, Su Y et al (2007) Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 49(3):432–439CrossRef Pilkey RM, Morton AR, Boffa MB, Noordhof C, Day AG, Su Y et al (2007) Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 49(3):432–439CrossRef
20.
Zurück zum Zitat Nagata Y, Inaba M, Imanishi Y, Okazaki H, Yamada S, Mori K et al (2015) Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis. Osteoporos Int 26(3):1053–1061CrossRef Nagata Y, Inaba M, Imanishi Y, Okazaki H, Yamada S, Mori K et al (2015) Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis. Osteoporos Int 26(3):1053–1061CrossRef
21.
Zurück zum Zitat Sato M, Ogawa T, Sugimoto H, Otsuka K, Nitta K (2012) Relation of carotid intima-media thickness and silent cerebral infarction to cardiovascular events and all-cause mortality in chronic hemodialysis patients. Intern Med 51(16):2111–2117CrossRef Sato M, Ogawa T, Sugimoto H, Otsuka K, Nitta K (2012) Relation of carotid intima-media thickness and silent cerebral infarction to cardiovascular events and all-cause mortality in chronic hemodialysis patients. Intern Med 51(16):2111–2117CrossRef
22.
Zurück zum Zitat Nishizawa Y, Shoji T, Maekawa K, Nagasue K, Okuno S, Kim M et al (2003) Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 41(3 Suppl 1):S76–S79CrossRef Nishizawa Y, Shoji T, Maekawa K, Nagasue K, Okuno S, Kim M et al (2003) Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 41(3 Suppl 1):S76–S79CrossRef
23.
Zurück zum Zitat Hojs R (2000) Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs 24(9):691–695CrossRef Hojs R (2000) Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs 24(9):691–695CrossRef
24.
Zurück zum Zitat Modi N, Kapoor A, Kumar S, Tewari S, Garg N, Sinha N (2006) Utility of carotid intimal medial thickness as a screening tool for evaluation of coronary artery disease in pre-transplant end stage renal disease. J Postgrad Med 52(4):266–270PubMed Modi N, Kapoor A, Kumar S, Tewari S, Garg N, Sinha N (2006) Utility of carotid intimal medial thickness as a screening tool for evaluation of coronary artery disease in pre-transplant end stage renal disease. J Postgrad Med 52(4):266–270PubMed
25.
Zurück zum Zitat Chen NX, Duan D, O’Neill KD, Moe SM (2006) High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21(12):3435–3442CrossRef Chen NX, Duan D, O’Neill KD, Moe SM (2006) High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21(12):3435–3442CrossRef
Metadaten
Titel
Osteocalcin and vascular calcification in hemodialysis patients: an observational cohort study
verfasst von
Hesham Kamal Habeeb Keryakos
Nagwa Ismail Okaily
Mariam Asaad Yacoub Boulis
Ahmed Mohamed Saadeldin Salama
Publikationsdatum
12.01.2021
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 5/2021
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02753-y

Weitere Artikel der Ausgabe 5/2021

International Urology and Nephrology 5/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.